Dow Jones

39,838.55

0.71%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

MRZM

Marizyme (QB) (MRZM)

Marizyme Inc (QB)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:MRZM

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
13/05/2024	15:50	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:MRZM	Marizyme Inc (QB)
06/05/2024	16:00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
06/02/2024	15:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:MRZM	Marizyme Inc (QB)
28/12/2023	19:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:MRZM	Marizyme Inc (QB)
14/11/2023	15:27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:MRZM	Marizyme Inc (QB)
17/10/2023	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:MRZM	Marizyme Inc (QB)
08/09/2023	09:22	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	USOTC:MRZM	Marizyme Inc (QB)
15/08/2023	15:15	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:MRZM	Marizyme Inc (QB)
31/07/2023	07:57	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:MRZM	Marizyme Inc (QB)
18/07/2023	15:59	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:MRZM	Marizyme Inc (QB)
12/07/2023	15:26	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:MRZM	Marizyme Inc (QB)
23/06/2023	15:55	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:MRZM	Marizyme Inc (QB)
23/06/2023	15:53	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:MRZM	Marizyme Inc (QB)
05/06/2023	15:20	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:MRZM	Marizyme Inc (QB)
02/06/2023	15:08	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:MRZM	Marizyme Inc (QB)
15/05/2023	15:13	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:MRZM	Marizyme Inc (QB)
26/04/2023	16:28	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:MRZM	Marizyme Inc (QB)
20/04/2023	14:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:MRZM	Marizyme Inc (QB)
31/03/2023	05:02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:MRZM	Marizyme Inc (QB)
09/02/2023	15:46	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:MRZM	Marizyme Inc (QB)
01/06/2022	14:22	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:MRZM	Marizyme Inc (QB)
31/03/2022	16:20	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:MRZM	Marizyme Inc (QB)
22/11/2021	12:26	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:MRZM	Marizyme Inc (QB)
15/11/2021	15:23	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:MRZM	Marizyme Inc (QB)
03/11/2021	05:01	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:MRZM	Marizyme Inc (QB)
05/08/2021	08:41	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	USOTC:MRZM	Marizyme Inc (QB)
31/03/2021	16:01	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:MRZM	Marizyme Inc (QB)
05/08/2020	08:59	Edgar (US Regulatory)	Amended Small Company Offering and Sale of Securities Without Registration (d/a)	USOTC:MRZM	Marizyme Inc (QB)
14/03/2019	07:14	InvestorsHub NewsWire	Marizyme, Inc.'s Krillase Therapeutic Platform Shows Wide Medical Application and Treatment Potential -- Spotlight Growth	USOTC:MRZM	Marizyme Inc (QB)
28/11/2018	15:08	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:MRZM	Marizyme Inc (QB)